Related Experiment Video
Updated: Jun 22, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
[Role of the independent microbiology laboratory in supporting infection control programs in small to mid-sized
1Miroku Medical Laboratory, Inc., Saku 384-2103, Japan. h-yanagisawa@miroku-lab.co.jp
Abstract:
With the revision of the Medical Service Law in 2006 by the Japanese Ministry of Health, Labour and Welfare (MHLW), all healthcare institutions are now required to implement a healthcare risk management program including infection control program. At a national level, an infection control surveillance program (JANIS) was implemented in July 2007. Regular weekly, monthly, and yearly infection control surveillance reports from independent microbiology laboratories can make significant contributions to infection control programs in small to mid-sized hospitals; furthermore, such programs are consistent with the framework of the MHLW's objective of strengthening risk management in healthcare institutions. Against the backdrop of current efforts to improve risk management, independent laboratories can make a significant contribution. Independent laboratories must play a role beyond merely receiving and processing specimens for microbiological examination. In addition to generating results for patients, hospital epidemiological data that contribute to local infection control programs must be a value-added component of the service. A major obstacle for independent laboratories to make a significant contribution to risk management is the current reimbursement system, which makes it economically impossible for independent laboratories to support infection control programs in healthcare institutions.
Insights
Independent laboratories can enhance healthcare infection control programs by providing valuable epidemiological data. However, current reimbursement systems hinder their ability to support these vital risk management initiatives.
Area of Science:
- Healthcare Management
- Infectious Disease Epidemiology
- Medical Microbiology
Context:
- Japanese Ministry of Health, Labour and Welfare (MHLW) revised the Medical Service Law in 2006, mandating healthcare risk management programs.
- A national infection control surveillance program (JANIS) was established in July 2007.
- Small to mid-sized hospitals can benefit from regular surveillance reports from independent microbiology laboratories.
Purpose:
- To explore the potential role of independent laboratories in strengthening healthcare risk management and infection control programs.
- To identify the contributions independent laboratories can offer beyond routine microbiological testing.
- To examine the financial barriers preventing independent laboratories from supporting hospital infection control initiatives.
Summary:
- Independent laboratories can provide crucial epidemiological data to support hospital infection control and risk management programs.
- These laboratories should offer value-added services, including data analysis for local infection control, not just specimen processing.
- The current reimbursement structure presents a significant economic obstacle for independent laboratories to effectively contribute to healthcare risk management.
Impact:
- Independent laboratories can significantly contribute to national healthcare risk management objectives.
- Enhanced infection control surveillance can improve patient safety in healthcare institutions.
- Policy adjustments in reimbursement are needed to enable independent laboratories to fully support infection control programs.
Related Concept Videos
Automated Microbial Diagnostics
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Key Techniques in Microbiology
Rapid Identification of Pathogens

